SEC Form 4 · accession 0001140361-26-036125
Grace Therapeutics, Inc. · GRCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Prashant Kohli
Officer — Chief Executive Officer · Director
Period of report
Sep 9, 2026
Accepted (ET)
Sep 10, 2026 · 7:30 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001444192
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 9, 2026 | P | 100,000 | $2.14 | A | 121,357 | D |
Table II — derivative securities
No Table II lines on this filing.